Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

InforSense GenSense Achieves GeneChip-compatible™ Status with the Affymetrix GeneChip® Microarray Platform

Published: Tuesday, August 07, 2007
Last Updated: Tuesday, August 07, 2007
Bookmark and Share
Affymetrix has become a member of InforSense’s Open Workflow Partner Network joining over 40 other partners in the program.

InforSense Ltd. has announced that it has joined the Affymetrix GeneChip-compatible Applications Program, and that its InforSense GenSense solution, has achieved GeneChip-compatible™ status with the Affymetrix GeneChip® microarray platform.

In addition, Affymetrix has become a member of InforSense’s Open Workflow Partner Network (OWPN) joining over 40 other partners in the program.

The integration will enable scientists to analyze and interpret both the Affymetrix Genome-Wide Human SNP 5.0 and SNP 6.0 arrays. Workflows provided with the solution also include access to Affymetrix Power Tools for Loss of Heterozygosity (LOH) and Copy Number Variation (CNV) as well as the Affymetrix calling algorithms, including BRLMM , BRLMM-p and Birdseed.

“We are please to welcome GenSense from Inforsense into the GeneChip-compatible Applications Program,” said Steve Lincoln, Vice-President of Informatics at Affymetrix. “GenSense is deeply integrated with the Affymetrix microarray platform at both the microarray data and annotations levels, enabling researchers to focus more of their efforts on the results and their scientific interpretation."

“Our relationship with Affymetrix enhances our joint customers’ ability to build ad-hoc analysis and data workflows for streamlining Genome Wide Association Studies,” said Jonathan Sheldon, CSO, InforSense. “We are very pleased to have Affymetrix as part of our Open Workflow Partner Network to continue expanding the capabilities available through the InforSense platform.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

InforSense Partners with U.K.’s Leading Institutions to Combat Alzheimer’s Disease
Translational research solution to help accelerate early diagnosis and personalized medicine treatments.
Wednesday, December 03, 2008
InforSense® Announces Conference Series
The InforSense Users Conference will provide opportunity to learn how InforSense KDE is being used to facilitate business-critical decision-making across a variety of industries.
Tuesday, November 14, 2006
Scientific News
Poverty Marks a Gene, Predicting Depression
New study of high-risk teens reveals a biological pathway for depression.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Gene That Lowers Heart Attack Risk Identified
Individuals with a rare twelve-letter deletion from a gene on chromosome 17 have significantly reduced non-HDL cholesterol levels and a 35% lower than average risk of heart disease.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!